Literature DB >> 15018788

Determination of paeoniflorin in rat hippocampus by high-performance liquid chromatography after intravenous administration of Paeoniae Radix extract.

Xihui He1, Dongming Xing, Yi Ding, Yaping Li, Lan Xiang, Wei Wang, Lijun Du.   

Abstract

A rapid and simple high-performance liquid chromatographic (HPLC) assay for the determination of paeoniflorin in rat hippocampus was developed in this study. The chromatographic analysis was carried out using reversed-phase isocratic elution with a Zorbax SB-C(18) column, a mobile phase of methanol-water (32:68, v/v), and detection by ultraviolet (UV) absorption at 233 nm. The lower limits of quantitation (LLQ) were 1 microg/ml for paeoniflorin. The calibration curve for paeoniflorin was linear (r = 0.9999) over the concentration range of 1-50 microg/ml. The coefficients of variation of intra- and inter-day assays were 7.00, 0.58, 1.46% and 5.48, 1.79, 1.70% at concentrations of 1, 10, 50 microg/ml, respectively. The recoveries of paeoniflorin from rat hippocampus were 98.28 +/- 2.14, 98.96 +/- 1.48, and 95.34 +/- 0.92 at concentrations of 1, 10 and 50 microg/ml, respectively. Stability studies showed that paeoniflorin was stable at temperatures of 2-8 degrees C in methanol for at least 20 days. The method was applied to determine the time course of paeoniflorin in rat hippocampus, following the administration of a 60 mg/kg i.v. dose of paeoniflorin in Paeoniae Radix extract to a male Wistar rat.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15018788     DOI: 10.1016/j.jchromb.2003.11.040

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  11 in total

1.  Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine A1 receptor in a manner different from its classical agonists.

Authors:  Da-Zhi Liu; Ke-Qiang Xie; Xin-Quan Ji; Yang Ye; Cheng-Liang Jiang; Xing-Zu Zhu
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

2.  Synergistic effects of Chuanxiong-Chishao herb-pair on promoting angiogenesis at network pharmacological and pharmacodynamic levels.

Authors:  Yan Wang; Gang Guo; Bin-Rui Yang; Qi-Qi Xin; Qi-Wen Liao; Simon Ming-Yuen Lee; Yuan-Jia Hu; Ke-Ji Chen; Wei-Hong Cong
Journal:  Chin J Integr Med       Date:  2017-05-27       Impact factor: 1.978

3.  Paeoniflorin Promotes Angiogenesis in A Vascular Insufficiency Model of Zebrafish in vivo and in Human Umbilical Vein Endothelial Cells in vitro.

Authors:  Qi-Qi Xin; Bin-Rui Yang; He-Feng Zhou; Yan Wang; Bo-Wen Yi; Wei-Hong Cong; Simon Ming-Yuen Lee; Ke-Ji Chen
Journal:  Chin J Integr Med       Date:  2016-06-09       Impact factor: 1.978

4.  Paeoniflorin, the Main Active Ingredient of Shuyu Capsule, Inhibits Cav1.2 and Regulates Calmodulin/Calmodulin-Dependent Protein Kinase II Signalling.

Authors:  Chunhong Song; Jieqiong Wang; Dongmei Gao; Yanhong Yu; Fang Li; Sheng Wei; Peng Sun; Meiyan Wang; Mingqi Qiao
Journal:  Biomed Res Int       Date:  2017-12-06       Impact factor: 3.411

5.  Paeoniflorin Inhibits Migration and Invasion of Human Glioblastoma Cells via Suppression Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition.

Authors:  Zhaotao Wang; Zhi Liu; Guoyong Yu; Xiaohu Nie; Weiqiang Jia; Ru-En Liu; Ruxiang Xu
Journal:  Neurochem Res       Date:  2018-02-08       Impact factor: 3.996

6.  Paeoniflorin exerts antitumor effects by inactivating S phase kinase-associated protein 2 in glioma cells.

Authors:  Jia Ouyang; Hui Xu; Ming Li; Xingliang Dai; Fengqing Fu; Xueguang Zhang; Qing Lan
Journal:  Oncol Rep       Date:  2017-12-28       Impact factor: 3.906

7.  Paeoniflorin ameliorates Aβ-stimulated neuroinflammation via regulation of NF-κB signaling pathway and Aβ degradation in C6 glial cells.

Authors:  Eun Ju Cho; Hyun Young Kim; Ah Young Lee
Journal:  Nutr Res Pract       Date:  2020-07-30       Impact factor: 1.926

8.  Paeoniflorin Inhibits EMT and Angiogenesis in Human Glioblastoma via K63-Linked C-Met Polyubiquitination-Dependent Autophagic Degradation.

Authors:  Zhi Liu; Zhaotao Wang; Danmin Chen; Xiaorui Liu; Guoyong Yu; Yan Zhang; Chen Chen; Ruxiang Xu; Yezhong Wang; Ru-En Liu
Journal:  Front Oncol       Date:  2022-07-26       Impact factor: 5.738

9.  Paeoniflorin inhibits excitatory amino acid agonist-and high-dose morphine-induced nociceptive behavior in mice via modulation of N-methyl-D-aspartate receptors.

Authors:  Yuh-Fung Chen; Ming-Ming Lee; Hsun-Lang Fang; Jhao-Guei Yang; Yu-Chien Chen; Huei-Yann Tsai
Journal:  BMC Complement Altern Med       Date:  2016-07-26       Impact factor: 3.659

10.  Paeoniflorin inhibits glioblastoma growth in vivo and in vitro: a role for the Triad3A-dependent ubiquitin proteasome pathway in TLR4 degradation.

Authors:  Zhaotao Wang; Guoyong Yu; Zhi Liu; Jianwei Zhu; Chen Chen; Ru-En Liu; Ruxiang Xu
Journal:  Cancer Manag Res       Date:  2018-04-27       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.